News

Landmark research published in Nature, supported by NIHR Leeds Biomedical Research Centre, has identified a previously overlooked type of circular DNA that may play a role in post-treatment recurrence in the most common form of childhood leukaemia.

A trial supported by NIHR Leeds BRC into removing incorrect penicillin allergy labels on GP records could combat antibiotic resistance and save lives, an NIHR-funded clinical trial led by the University of Leeds has found.

Closing date for applications: 17:00 hrs 5th September 2025 Interviews week commencing 9th October 2025 The NIHR Leeds Biomedical Research Centre is delighted to invite applications for the 2025 Pre-application support fellowships: Round 2. In order to support applicants applying for competitive funded career development fellowships, we are holding a…

When it comes to staying healthy, knowledge really is power. Imagine if we could catch diseases earlier, treat them faster, and even prevent them altogether — that’s the promise of In-Vitro Diagnostics, or IVDs.

A new research project has revealed the hidden struggle of people living with polymyalgia rheumatica (PMR)—a painful, often misunderstood inflammatory condition that primarily affects older adults.

We are delighted to announce that Professor Helena Marzo-Ortega has been formally recognised by the British Society for Rheumatology (BSR) for her contribution to the British Society for Rheumatology Register in Psoriatic Arthritis (BSR-PsA).

A collaboration between one of our colleagues and a Leeds data scientist has inspired her to continue a career in clinical care.

NIHR Leeds BRC hosted a joint event to celebrate International Clinical Trials Day, highlighting the role trials play in advancing medical research and improving healthcare. The event, organised in collaboration NIHR Leeds Clinical Research Facility, recognised the life-changing impact of health and care research and the people who make it…

The fourth instalment of the Moving Forward Infection Diagnostics event series recently took place at Nexus Leeds, drawing leading voices from across the healthcare and diagnostics sectors for a day of collaboration, insight, and innovation.

A national clinical trial supported by the NIHR Leeds Biomedical Research Centre has demonstrated that a novel combination of targeted therapies can extend remission and improve quality of life for patients with relapsed myeloma, a blood cancer that accounts for 1 in every 50 new cancer diagnoses in the UK.

As we mark Vasculitis Awareness Month, we are proud to share that NIHR Leeds BRC has partnered with Leeds Institute for Data Analytics (LIDA) on a new data study on giant cell arthritis (GCA), as part of a programme to foster talent in upcoming data scientists.

Our colleague, Professor Francesco Del Gado, has had a collaborative study on systemic sclerosis with Yale University published in The Lancet Rheumatology.

Our colleague Professor Paul Emery CBE has been ranked as the number 1 immunologist in the UK and 21 in the world by a leading academic platform for researchers. He was also recognised with the Immunology Leader Award for 2025.

Congratulations to our colleagues Professor Helena Marzo-Ortega, Dr Jane Freeston and Dr Christian Sellinger who have all been recognised by the National Axial Sponyloarthritis Society (NASS) for their outstanding contributions to improving the care of patients living with this condition.

Join us for a two-day course on Giant Cell Arteritis (GCA)
Save the date: Thursday 9th & Friday 10th October